Role of Clinical Pharmacist in the healthcare management of Type II Diabetes mellitus patients

Not yet recruiting

Conditions: Type 2 diabetes mellitus with other specified complications,

Registration Number: CTRI/2019/02/017516

Brief Summary: The term diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both.

In 2017, there were 451 million (age 18-99 years) people with diabetes worldwide.

It is predicted that by 2030 diabetes mellitus may afflict up to 79.4 million individuals in India, while China (42.3 million) and the United States (30.3 million) will also see significant increases in those affected by the disease.

The total prevalence of diabetes in adults in India was 8.8 % in the year 2017.

Intensive lifestyle interventions involving a combination of diet and physical activity can delay or prevent diabetes among people at high risk.

Diabetes education and training is of critical importance and should be considered an integral part of diabetes prevention and care.

Available literature suggests that the management of diabetes in India is sub-optimal for the majority of patients. Only 40â€“50% of individuals achieve the target for glycemic control, while lower numbers achieve targets for blood pressure and lipid control.

Collaboration among physicians, nurses, dieticians, and pharmacists is required to ensure optimum patient care and adequate diabetes management.

International standards for diabetes care have recognized the crucial role of pharmacists in diabetes management.

There are lack of studies in India that analyze the attitudes and roles of pharmacist in diabetes management. The present study is an attempt in this direction.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 200

Inclusion Criteria

Known case of Type II Diabetes patients who attended the OP department.
Patient whose HbA1C is â‰¥ 7 Patients of both genders >18 years of age.

Exclusion Criteria

Patients who are type 1 diabetes, gestational diabetes and psychiatric illness.
Patients who are not willing to participate in the study.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcomes:	Measurement at Baseline visit and at the end of 3 months
Assessment of patient satisfaction of care	Measurement at Baseline visit and at the end of 3 months
Assessment of medication adherence by MARS scale	Measurement at Baseline visit and at the end of 3 months

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes:	Improvement in laboratory parameters(Blood Pressure, Blood glucose, Lipid profile, S Creatinine)

Trial Locations

Locations (1): SRM Medical College Hospital and Research Centre
🇮🇳
Kancheepuram, TAMIL NADU, India
SRM Medical College Hospital and Research Centre
🇮🇳Kancheepuram, TAMIL NADU, India
PAULIN C VARGHESE
Principal investigator
9600054755
angelopsr47@yahoo.com